AZA had a dose- and time-dependent cytotoxic effects on AML cell lines and can sensitize AML cells to chemotherapy; more importantly, AZA can inhibit the expression of Trx/Jab1 against AML cells (Pan et al., 2017). Here, COPS5 is linked to acute myeloid leukemia.